🇺🇸 FDA
Patent

US 7335640

Administration of hypocretin-1 for treatment of narcolepsy

granted A61KA61K38/22

Quick answer

US patent 7335640 (Administration of hypocretin-1 for treatment of narcolepsy) held by The Regents of the University of California expires Mon Feb 21 2028 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Feb 26 2008 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 21 2028 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
18
CPC classes
A61K, A61K38/22